<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
72319-030-06
</NDCCode>
<PackageDescription>
1000 TABLET in 1 BOTTLE (72319-030-06)
</PackageDescription>
<NDC11Code>
72319-0030-06
</NDC11Code>
<ProductNDC>
72319-030
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Methscopolamine Bromide
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Methscopolamine Bromide
</NonProprietaryName>
<DosageFormName>
TABLET
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20241218
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA216786
</ApplicationNumber>
<LabelerName>
i3 Pharmaceuticals, LLC
</LabelerName>
<SubstanceName>
METHSCOPOLAMINE BROMIDE
</SubstanceName>
<StrengthNumber>
5
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes>
Anticholinergic [EPC], Cholinergic Antagonists [MoA]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2025-02-27
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20241218
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>